甲状腺毒症中的生长
Growth in thyrotoxicosis.
作者信息
Buckler J M, Willgerodt H, Keller E
出版信息
Arch Dis Child. 1986 May;61(5):464-71. doi: 10.1136/adc.61.5.464.
Abstract
To study the effect of thyrotoxicosis on growth, 46 children and adolescents presenting with thyrotoxicosis have been reviewed and followed up for several years, in most cases until adult height was achieved. At presentation the children were underweight for height but were above expected heights even if already well advanced in puberty. Despite bone ages often being very advanced at diagnosis, the condition had no adverse effect on ultimate stature, which was commonly greater than that expected on the basis of parental height. Wight was rapidly regained on treatment, but nevertheless the younger subjects continued to be underweight despite adequate prolonged control of thyrotoxicosis.
摘要
为研究甲状腺毒症对生长的影响，对46例患有甲状腺毒症的儿童和青少年进行了回顾性研究，并随访数年，多数情况下随访至达到成人身高。就诊时，这些儿童身高对应的体重低于正常水平，但即便青春期已发育至较成熟阶段，其身高仍高于预期。尽管诊断时骨龄往往超前，但该病症对最终身高并无不利影响，其身高通常高于基于父母身高所预期的身高。治疗后体重迅速恢复，但较年轻的患者尽管甲状腺毒症得到了充分且长期的控制，体重仍持续低于正常水平。
相似文献
1
Growth in thyrotoxicosis.甲状腺毒症中的生长
Arch Dis Child. 1986 May;61(5):464-71. doi: 10.1136/adc.61.5.464.
2
Growth in childhood thyrotoxicosis.
Eur J Pediatr. 1999 Oct;158(10):776-9. doi: 10.1007/s004310051202.
3
Growth pattern of childhood thyrotoxicosis: longitudinal follow-up to final height.儿童甲状腺毒症的生长模式：对最终身高的纵向随访
J Med Assoc Thai. 2006 Sep;89(9):1396-9.
4
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.生长激素治疗与青春期对特发性身材矮小和生长激素缺乏症儿童骨骼及身体成分的影响。
Bone. 2005 Nov;37(5):642-50. doi: 10.1016/j.bone.2005.06.012. Epub 2005 Sep 1.
5
Acceleration of growth and bone maturation in childhood thyrotoxicosis.儿童甲状腺毒症时生长及骨骼成熟加速。
J Pediatr. 1973 Aug;83(2):233-6. doi: 10.1016/s0022-3476(73)80481-0.
6
Adult outcome of normal children who are short or underweight at age 7 years.7岁时身材矮小或体重不足的正常儿童的成人结局。
BMJ. 1995 Mar 18;310(6981):696-700. doi: 10.1136/bmj.310.6981.696.
7
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.对身材矮小青少年使用促黄体生成素释放激素激动剂进行治疗。
N Engl J Med. 2003 Mar 6;348(10):908-17. doi: 10.1056/NEJMoa013555.
8
The growth of twins between the ages of 2 and 9 years.2至9岁双胞胎的生长情况。
Ann Hum Biol. 2008 Jan-Feb;35(1):75-92. doi: 10.1080/03014460701809000.
9
Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.出生时小于胎龄的矮小儿童接受三年生长激素治疗后，在停止治疗五年后会出现重要的追赶生长。
J Clin Endocrinol Metab. 2004 Mar;89(3):1234-9. doi: 10.1210/jc.2003-030962.
10
Effect of GnRHa 3.75 mg subcutaneously every 6 weeks on adult height in girls with idiopathic central precocious puberty.每6周皮下注射3.75毫克促性腺激素释放激素类似物（GnRHa）对特发性中枢性性早熟女童成年身高的影响。
J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):839-46. doi: 10.1515/jpem-2014-0305.
引用本文的文献
1
Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review and recommendations.青春期身材高大和巨人症：临床和遗传方面——文献综述及建议。
J Endocrinol Invest. 2024 Apr;47(4):777-793. doi: 10.1007/s40618-023-02223-z. Epub 2023 Oct 27.
2
Regional Differences in Height, Weight, and Body Composition may Result from Photoperiodic Responses: An Ecological Analysis of Japanese Children and Adolescents.身高、体重和身体成分的区域差异可能源于光周期反应：对日本儿童和青少年的生态分析
J Circadian Rhythms. 2021 Feb 22;19:3. doi: 10.5334/jcr.198.
3
Sexual precocity in a girl with early-onset Graves' disease.一名患有早发性格雷夫斯病的女孩出现性早熟。
Clin Pediatr Endocrinol. 2018;27(3):165-169. doi: 10.1297/cpe.27.165. Epub 2018 Jul 31.
4
Pericardial Effusion in the Emergency Department.急诊科的心包积液
Endocrinologist. 2004 Jul;14(4):212-215. doi: 10.1097/01.ten.0000134730.77404.a2.
5
Autoimmune thyroid diseases in children.儿童自身免疫性甲状腺疾病
J Thyroid Res. 2010 Dec 14;2011:675703. doi: 10.4061/2011/675703.
本文引用的文献
1
TREATMENT OF JUVENILE THYROTOXICOSIS.青少年甲状腺毒症的治疗
J Pediatr. 1963 Sep;63:402-7. doi: 10.1016/s0022-3476(63)80427-8.
2
Skeletal age changes in puberty.青春期骨骼年龄的变化。
Arch Dis Child. 1984 Feb;59(2):115-9. doi: 10.1136/adc.59.2.115.
3
Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.1965年英国儿童从出生到成年的身高、体重、身高增长速度和体重增长速度标准。I
Arch Dis Child. 1966 Oct;41(219):454-71. doi: 10.1136/adc.41.219.454.
4
Grave'S's disease, an unusual complication: raised intracranial pressure due to premature fusion of skull sutures.格雷夫斯病，一种罕见的并发症：因颅骨缝过早融合导致颅内压升高。
Arch Dis Child. 1969 Apr;44(234):252-7. doi: 10.1136/adc.44.234.252.
5
Hyperthyroidism under 2 years of age.2岁以下的甲状腺功能亢进症。
Am J Dis Child. 1970 Aug;120(2):157-9. doi: 10.1001/archpedi.1970.02100070101015.
6
Catch-up in height and skeletal maturity in children on long-term treatment for hypothyroidism.接受长期甲状腺功能减退治疗儿童的身高追赶与骨骼成熟情况
Z Kinderheilkd. 1972;112(1):1-17. doi: 10.1007/BF00491961.
7
Premature craniosynostosis: A common complication of juvenile thyrotoxicosis.
J Pediatr. 1978 Aug;93(2):188-91. doi: 10.1016/s0022-3476(78)80493-4.
8
Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents.毒性弥漫性甲状腺肿（格雷夫斯病）的抗甲状腺药物治疗：儿童和青少年30年经验
J Pediatr. 1977 Aug;91(2):313-20. doi: 10.1016/s0022-3476(77)80843-3.
Zotero 插件